Paper36923693
A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA.
Rupp DC and 6 others. Clin Cosmet Investig Dermatol, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA. Papers, record 36923693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17097394 | Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study. | J Am Acad Dermatol | 2006 | https://conductscience.org/library/papers/17097394 | PubMed |
| 2 | 33456901 | Non-inferiority statistics and equivalence studies. | BJA Educ | 2019 | https://conductscience.org/library/papers/33456901 | PubMed |
| 3 | 21825992 | Compositional differences among commercially available botulinum toxin type A. | Curr Opin Ophthalmol | 2011 | https://conductscience.org/library/papers/21825992 | PubMed |
| 4 | 11714400 | Noninferiority trials. | Curr Control Trials Cardiovasc Med | 2000 | https://conductscience.org/library/papers/11714400 | PubMed |
| 5 | 23458294 | The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice. | Dermatol Surg | 2013 | https://conductscience.org/library/papers/23458294 | PubMed |
| 6 | 25059456 | Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. | J Neural Transm (Vienna) | 2015 | https://conductscience.org/library/papers/25059456 | PubMed |
| 7 | 23400888 | Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. | Pharmacotherapy | 2013 | https://conductscience.org/library/papers/23400888 | PubMed |
| 8 | 27268041 | In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA. | Neurosci Lett | 2016 | https://conductscience.org/library/papers/27268041 | PubMed |
| 9 | 29633692 | Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal. | Funct Neurol | 2018 | https://conductscience.org/library/papers/29633692 | PubMed |
| 10 | 25336912 | Botulinum toxin type A products are not interchangeable: a review of the evidence. | Biologics | 2014 | https://conductscience.org/library/papers/25336912 | PubMed |
| 11 | 24587850 | Comparison and overview of currently available neurotoxins. | J Clin Aesthet Dermatol | 2014 | https://conductscience.org/library/papers/24587850 | PubMed |
| 12 | 23868503 | Diffusion, spread, and migration of botulinum toxin. | Mov Disord | 2013 | https://conductscience.org/library/papers/23868503 | PubMed |
| 13 | 30893169 | Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study. | Dermatol Surg | 2019 | https://conductscience.org/library/papers/30893169 | PubMed |
| 14 | 26509943 | A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines. | Dermatol Surg | 2015 | https://conductscience.org/library/papers/26509943 | PubMed |
| 15 | 20369902 | Botulinum toxin: examining duration of effect in facial aesthetic applications. | Am J Clin Dermatol | 2010 | https://conductscience.org/library/papers/20369902 | PubMed |
| 16 | 27673516 | Advancements and Refinement in Facial Neuromodulators. | Plast Reconstr Surg | 2016 | https://conductscience.org/library/papers/27673516 | PubMed |
| 17 | 32866999 | The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II. | J Cosmet Dermatol | 2020 | https://conductscience.org/library/papers/32866999 | PubMed |
| 18 | 11600142 | A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. | Toxicon | 2001 | https://conductscience.org/library/papers/11600142 | PubMed |
| 19 | 28356439 | Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. | Pharmacol Rev | 2017 | https://conductscience.org/library/papers/28356439 | PubMed |
| 20 | 22069680 | Characterization of SNARE cleavage products generated by formulated botulinum neurotoxin type-a drug products. | Toxins (Basel) | 2010 | https://conductscience.org/library/papers/22069680 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957223 | Dose-dependent Effects of Botulinum Toxin Type E in the Mouse Digit Abduction Score Model. | In Vivo | 2026 | https://conductscience.org/library/papers/42957223 | PubMed |
| 42429953 | Botulinum Toxin A Myths, Evidence, and Global Media Narratives. | Aesthetic Plast Surg | 2026 | https://conductscience.org/library/papers/42429953 | PubMed |
| 41745765 | Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41745765 | PubMed |
| 41508559 | Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis of Clinical Studies. | J Cosmet Dermatol | 2026 | https://conductscience.org/library/papers/41508559 | PubMed |
| 41150202 | RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/41150202 | PubMed |
| 40593115 | Decades of Scientific Data and Global Media Reporting on Complications in Non-surgical Aesthetic Treatments for a Transparent Safety Profile: Kissing Snow White Awake. | Aesthetic Plast Surg | 2025 | https://conductscience.org/library/papers/40593115 | PubMed |
| 40423313 | Preclinical Evaluation of Botulinum Toxin Type E (TrenibotulinumtoxinE) Using the Mouse Digit Abduction Score (DAS) Assay. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40423313 | PubMed |
| 38025648 | Tailored Indications for Different Neurotoxins. | Plast Reconstr Surg Glob Open | 2023 | https://conductscience.org/library/papers/38025648 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| SNAP25 | 6616 | PubTator's text mining | https://conductscience.org/library/genes/6616 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36923693
GET https://conductscience.org/api/papers/v1/36923693/references?page=2